中文 | English
Return
Total: 50 , 1/5
Show Home Prev Next End page: GO
Author:(Ningning PAN)

1.A Single-Arm Phase II Clinical Trial of Fulvestrant Combined with Neoadjuvant Chemotherapy of ER+/HER2– Locally Advanced Breast Cancer: Integrated Analysis of 18F-FES PET-CT and Metabolites with Treatment Response

Qing SHAO ; Ningning ZHANG ; Xianjun PAN ; Wenqi ZHOU ; Yali WANG ; Xiaoliang CHEN ; Jing WU ; Xiaohua ZENG

Cancer Research and Treatment 2025;57(1):126-139

2.A study on clinical manifestations and correlation of symptoms of traditional Chinese medicine in emigrated plateau population

Tiantian XIA ; Wei ZHOU ; Li TONG ; Pan SHEN ; Ningning WANG ; Nan ZHANG ; Zhexin NI ; Yue GAO

Military Medical Sciences 2025;49(8):610-616

3.A Single-Arm Phase II Clinical Trial of Fulvestrant Combined with Neoadjuvant Chemotherapy of ER+/HER2– Locally Advanced Breast Cancer: Integrated Analysis of 18F-FES PET-CT and Metabolites with Treatment Response

Qing SHAO ; Ningning ZHANG ; Xianjun PAN ; Wenqi ZHOU ; Yali WANG ; Xiaoliang CHEN ; Jing WU ; Xiaohua ZENG

Cancer Research and Treatment 2025;57(1):126-139

4.A Single-Arm Phase II Clinical Trial of Fulvestrant Combined with Neoadjuvant Chemotherapy of ER+/HER2– Locally Advanced Breast Cancer: Integrated Analysis of 18F-FES PET-CT and Metabolites with Treatment Response

Qing SHAO ; Ningning ZHANG ; Xianjun PAN ; Wenqi ZHOU ; Yali WANG ; Xiaoliang CHEN ; Jing WU ; Xiaohua ZENG

Cancer Research and Treatment 2025;57(1):126-139

5.Familial erythrocytosis type 2 due to VHL germline mutations: a case report and literature review

Ningning LIU ; Lijuan PAN ; Zhijian XIAO ; Zefeng XU

Chinese Journal of Hematology 2025;46(1):75-80

6.Efficacy and survival outcomes of patients with lymphocytic variant hypereosinophilic syndrome

Shiqiang QU ; Ningning LIU ; Tiejun QIN ; Zefeng XU ; Bing LI ; Lijuan PAN ; Meng JIAO ; Qingyan GAO ; Huijun WANG ; Xiaofei AI ; Zhijian XIAO

Chinese Journal of Hematology 2025;46(7):611-617

7.Familial erythrocytosis type 2 due to VHL germline mutations: a case report and literature review

Ningning LIU ; Lijuan PAN ; Zhijian XIAO ; Zefeng XU

Chinese Journal of Hematology 2025;46(1):75-80

8.Efficacy and survival outcomes of patients with lymphocytic variant hypereosinophilic syndrome

Shiqiang QU ; Ningning LIU ; Tiejun QIN ; Zefeng XU ; Bing LI ; Lijuan PAN ; Meng JIAO ; Qingyan GAO ; Huijun WANG ; Xiaofei AI ; Zhijian XIAO

Chinese Journal of Hematology 2025;46(7):611-617

9.Tumor-intrinsic PRMT5 upregulates FGL1 via methylating TCF12 to inhibit CD8+ T-cell-mediated antitumor immunity in liver cancer.

Jiao SUN ; Hongfeng YUAN ; Linlin SUN ; Lina ZHAO ; Yufei WANG ; Chunyu HOU ; Huihui ZHANG ; Pan LV ; Guang YANG ; Ningning ZHANG ; Wei LU ; Xiaodong ZHANG

Acta Pharmaceutica Sinica B 2025;15(1):188-204

10.Clinical characteristics and pregnancy outcomes of multifetal pregnancy reduction: a 12-year cohort study

Li LI ; Yanyi LI ; Rui YANG ; Mengjie FAN ; Shuo YANG ; Jia LI ; Ying SONG ; Ningning PAN ; Tian TIAN ; Caihong MA ; Rong LI ; Ping LIU ; Jie QIAO

Chinese Journal of Reproduction and Contraception 2024;44(8):784-790

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 50 , 1/5 Show Home Prev Next End page: GO